Lantus vs Wegovy: side-by-side comparison
Lantus (Insulin Glargine) and Wegovy (Semaglutide) both belong to the Diabetes Treatment class. They share clinical context but use different active ingredients. The choice between them depends on mechanism nuances, side-effect profile and individual response.
| Property | Lantus | Wegovy |
|---|---|---|
| Active ingredient | Insulin Glargine | Semaglutide |
| Manufacturer | Sanofi | Novo Nordisk |
| Class | Diabetes Treatment | Diabetes Treatment |
| Strengths | 100 IU/mL | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg |
| Forms | pre-filled pen, vial | pre-filled pen |
What's the same
Lantus and Wegovy both belong to the Diabetes Treatment class and are used for partially overlapping indications. The active ingredients — Insulin Glargine vs Semaglutide — share the same therapeutic approach, so many safety and management points carry across both.
Key differences
Meaningful differences are in active ingredient (Insulin Glargine vs Semaglutide), strengths (100 IU/mL vs 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg), forms (pre-filled pen, vial vs pre-filled pen), and the mechanism, half-life and side-effect nuances that distinguish members of the class.
Mechanism and action
Lantus: Insulin glargine binds the insulin receptor with similar affinity to human insulin, activating intracellular signalling that increases glucose uptake in muscle and adipose tissue, suppresses hepatic glucose production an… Wegovy: Wegovy acts on the GLP-1 receptor in the central nervous system and gastrointestinal tract to reduce appetite, slow gastric emptying and increase satiety.
When Lantus is preferred
The medication is indicated in adults and paediatric patients with type 1 diabetes mellitus, and in adults with type 2 diabetes mellitus when basal insulin is required.
When Wegovy is preferred
Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI 30 or higher) or with overweight (BMI 27 or higher) and at least one weight-related comorbidity such as hypertension, dyslipidaemi…
Frequently asked questions
Is Lantus or Wegovy better? ▾
There is no single answer. Lantus and Wegovy both belong to the Diabetes Treatment class but differ in mechanism nuances, half-life and side-effect profile. Preference depends on the patient, the prescriber and prior response to other therapies.
Can I switch from Lantus to Wegovy? ▾
Switching within the Diabetes Treatment class is done under supervision, typically using equivalent doses and a follow-up period to confirm response and tolerance. It is not a self-directed decision.
Do Lantus and Wegovy have the same side effects? ▾
They share many of the Diabetes Treatment class side effects, with differences from mechanism and dose. Each medication's prescribing information lists specifics.
More Lantus comparisons
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.